| Knowledge4COVID-19

Property	Value
is ?:annotates of	<https://research.tib.eu/covid-19/entity/33741357_HAS_TOPIC_C0003253> <https://research.tib.eu/covid-19/entity/33741357_HAS_TOPIC_C0036667> <https://research.tib.eu/covid-19/entity/33741357_HAS_TOPIC_C0036668> <https://research.tib.eu/covid-19/entity/33741357_HAS_TOPIC_C0037791> <https://research.tib.eu/covid-19/entity/33741357_HAS_TOPIC_C0042196> <https://research.tib.eu/covid-19/entity/33741357_HAS_TOPIC_C0086418> <https://research.tib.eu/covid-19/entity/33741357_HAS_TOPIC_C0205991> <https://research.tib.eu/covid-19/entity/33741357_HAS_TOPIC_C5203670> <https://research.tib.eu/covid-19/entity/33741357_HAS_TOPIC_C5203676> <https://research.tib.eu/covid-19/entity/33741357_HAS_TOPIC_C5387588> <https://research.tib.eu/covid-19/entity/33741357_HAS_TOPIC_C5392141> <https://research.tib.eu/covid-19/entity/33741357_HAS_TOPIC_C5398043>
?:authorAffiliation	[\'Department of Clinical Pathology, Hospital of Bolzano, Bolzano, Italy. Electronic address: thomas.mueller@sabes.it.\']
?:citedBy	-1
?:creator	<https://research.tib.eu/covid-19/entity/Mueller_Thomas>
?:doi	<https://research.tib.eu/covid-19/entity/S0009-8981%2821%2900083-810.1016/j.cca.2021.03.007>
?:doi	S0009-8981(21)00083-810.1016/j.cca.2021.03.007
?:hasPublicationType	<https://research.tib.eu/covid-19/entity/Journal_Article>
?:journal	Clinica chimica acta; international journal of clinical chemistry
is ?:pmid of	<https://research.tib.eu/covid-19/entity/33741357>
?:pmid	<https://research.tib.eu/covid-19/entity/33741357>
?:pmid	33741357
?:publication_isRelatedTo_Disease	<https://research.tib.eu/covid-19/entity/Covid-19>
?:rankingScore_SJR	-1.0
?:rankingScore_hIndex	-1
is ?:relation_isRelatedTo_publication of	<https://research.tib.eu/covid-19/entity/C0027361_LOCATION_OF_C0003241> <https://research.tib.eu/covid-19/entity/C0030705_LOCATION_OF_C0003241> <https://research.tib.eu/covid-19/entity/C0442749_PROCESS_OF_C0018724>
?:title	Antibodies against severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) in individuals with and without COVID-19 vaccination: A method comparison of two different commercially available serological assays from the same manufacturer.
?:type	<https://research.tib.eu/covid-19/vocab/Publication> <https://research.tib.eu/covid-19/vocab/Publication_Author>
?:year	2021

Metadata

Anon_0

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://purl.org/net/provenance/ns#DataItem>

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://www.w3.org/2004/03/trix/rdfg-1/Graph>

<http://xmlns.com/foaf/0.1/primaryTopic>

<https://research.tib.eu/covid-19/entity/C0424811_T184>

<http://xmlns.com/foaf/0.1/topic>

Anon_0

<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes>

<https://research.tib.eu/covid-19/data/entity/C0424811_T184>

<http://purl.org/net/provenance/ns#createdBy>

Anon_1 (more)

expand all